Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
NCT01177657 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1944
Last updated 2012-11-19
Summary
The purpose of this study is to estimate the effectiveness of 2 doses of Rotarix™ vaccination in preventing rotavirus severe gastroenteritis among children hospitalized in Belem area, Brazil.
Conditions
- Rotavirus Gastroenteritis
Interventions
- PROCEDURE
-
Stool sampling
Stool samples collected and checked for the presence of rotavirus
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Min Age
- 12 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2011-05-31
- Completion
- 2011-05-31
Countries
- Brazil
Study Locations
More Related Trials
-
Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)
NCT00329745 ·Status: COMPLETED ·Phase: PHASE3
-
Gastroenteritis From Rotavirus Infection in Brazilian Children Less Than 5 Years of Age (Study V260-031).
NCT01195844 ·Status: TERMINATED
-
Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™
NCT01435967 ·Status: COMPLETED
-
Study to Evaluate the Safety of Rotarix™ in Chinese Children
NCT01086436 ·Status: COMPLETED ·Phase: PHASE1
-
ROTATEQ Reexamination Study (V260-037)
NCT01074242 ·Status: COMPLETED
-
Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules
NCT01266850 ·Status: COMPLETED ·Phase: PHASE4
-
Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™
NCT01511133 ·Status: COMPLETED
-
Effectiveness of Monovalent Rotavirus Vaccine (RV1)
NCT01871038 ·Status: COMPLETED
-
Surveillance of Rotavirus Gastroenteritis in Children <5 Years
NCT01363726 ·Status: UNKNOWN
-
Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana
NCT01575197 ·Status: COMPLETED ·Phase: PHASE4
-
Rotavirus Vaccine Produced by Butantan Institute
NCT00981669 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome
NCT00767364 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)
NCT02062385 ·Status: COMPLETED ·Phase: PHASE3
-
Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia
NCT03602053 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine
NCT01061658 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants
NCT06200844 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)
NCT00496054 ·Status: COMPLETED ·Phase: PHASE3
-
Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine
NCT01738074 ·Status: UNKNOWN ·Phase: PHASE3
-
Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island
NCT01026779 ·Status: COMPLETED
-
A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E
NCT01305109 ·Status: UNKNOWN ·Phase: PHASE3
-
Special Drug Use Investigation for ROTARIX®
NCT01636739 ·Status: COMPLETED
-
An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq)
NCT01960725 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Rotavirus Vaccine Introduction for South Australian Children
NCT01472575 ·Status: UNKNOWN
-
Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam
NCT03367559 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.
NCT00740935 ·Status: COMPLETED ·Phase: PHASE4